MB
Mohit Bansal Wells Fargo Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
39
Avg Return
Past Year
Past Year
9.3%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
76.9%
Neutral
23.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Upgraded
| $125 |
22%
upside
| 1 | +4.6% |
0
%
| 24 Nov ‘25 9 days ago |
|
|
|
Equal-Weight
Maintained
| $700 |
3%
downside
| 2 | -8% |
0
%
| 20 Nov ‘25 13 days ago |
|
|
|
Overweight
Maintained
| $235 |
41%
upside
| 1 | +12% |
0
%
| 18 Nov ‘25 15 days ago |
|
|
|
Equal-Weight
Maintained
| $3 |
20%
downside
| 1 | – |
–
| 11 Nov ‘25 22 days ago |
|
|
|
Overweight
Maintained
| $55 |
40%
upside
| 2 | +1.7% |
0
%
| 11 Nov ‘25 22 days ago |
|
|
|
Overweight
Maintained
| $300 |
13%
downside
| 1 | +16% |
0
%
| 5 Nov ‘25 28 days ago |
|
|
|
Overweight
Maintained
| $145 |
16%
upside
| 1 | +9.4% |
0
%
| 31 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $70 |
29%
upside
| 1 | +3.1% |
0
%
| 28 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $260 |
13%
upside
| 1 | +7.8% |
0
%
| 12 Sep ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $35 |
0%
upside
| 1 | +28% |
0
%
| 11 Sep ‘25 2 months ago |
|
|
|
Overweight
Initiated
| $4 |
53%
upside
| 1 | +53% |
0
%
| 11 Sep ‘25 2 months ago |
|